Land: Zuid-Afrika
Taal: Engels
Bron: South African Health Products Regulatory Authority (SAHPRA)
Adcock
ADCO-ATENOLOL TABLETS 50 mg ADCO-ATENOLOL TABLETS 100 mg SCHEDULING STATUS: S3 PROPRIETARY NAME: (and dosage form) ADCO-ATENOLOL TABLETS 50 mg ADCO-ATENOLOL TABLETS 100 mg COMPOSITION: ADCO-ATENOLOL TABLETS 50 mg contain 50 mg atenolol . ADCO-ATENOLOL TABLETS 100 mg contain 100 mg atenolol. PHARMACOLOGICAL CLASSIFICATION: A 5.2 Adrenolytics (Sympathicolytics) PHARMACOLOGICAL ACTION: Atenolol ( ADCO-ATENOLOL TABLETS) is a beta-adrenoceptor blocking agent which acts preferentially on beta- adrenergic receptors in the myocardium. It has no intrinsic activity and minimal membrane stabilizing properties. Atenolol does not cross the blood : brain barrier to a significant extent. INDICATIONS: Management of angina pectoris and hypertension. CONTRA-INDICATIONS: ADCO-ATENOLOL TABLETS should not be used: 1. In the presence of second or third degree heart block. 2. With myocardial depressant agents such as quinidine, procainamide or lignocaine which may enhance the effects of the atenolol. With verapamil, neither medicines should be administered within several days of discontinuing the other. Particular caution should be exercised with patients suffering from the following; asthma, bronchitis, chronic respiratory diseases, bradycardia less than 50 per minute, peripheral vascular diseases and Raynaud's phenomenon. 3. After prolonged fasting. 4. In patients with metabolic acidosis (eg. in diabetes). 5. In cardiac failure, unless or until signs of failure are controlled with digitalis and/or diuretics. The normal dose of ADCO-ATENOLOL should be reduced in elderly patients or in patients suffering from renal dysfunction. In the peri-operative period it is generally unwise to reduce the dosage of ADCO-ATENOLOL therapy to which the patient is accustomed, as there may be danger of aggravation of angina pect Lees het volledige document